answer text |
<p>The Department has well established procedures to deal with supply issues with
prescription medicines and works with the Medicines and Healthcare products Regulatory
Agency, NHS England and industry to prevent shortages and ensure that any risks to
patients are minimised should they arise.</p><p>We are aware of supply issues with
some medicines used in the treatment of attention deficit hyperactivity disorder.
However, alternative products remain available and communications have been issued
to the National Health Service to provide advice.</p>
|
|